Drug · DIN 02569833
YESINTEK
SINGLE-USE PREFILLED AUTO-INJECTOR
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 14, 2026.
- Drug Identification Number (DIN)
- 02569833
- Company (DIN owner)
- Biocon Biologics Canada IncToronto, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Ustekinumab L04AC05
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| USTEKINUMAB | 45 MG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 14, 2026: NOC 37900Supplement to a New Drug Submission (SNDS) · Addition of a primary container closure system
Other DINs named YESINTEK
- DIN 02562081 · Marketed
- DIN 02562103 · Marketed
- DIN 02566478 · Approved
- DIN 02569841 · Approved